Catalyst Wire Dossier Catalyst Wire Dossier

Z-521 (Oral Sodium Phosphate)

sodium phosphate · Zeria Pharmaceutical
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Z-521 (Oral Sodium Phosphate), covering 2013-10-01 to 2013-10-01. Get the full timeline:

Most recent: Clinical Trial Update: Therapeutic Use of Oral Sodium Phosphate (Z-521) in Primary Hypophosphatemic Rickets [Phase 3]

See pricing